Join us in raising awareness about American Diabetes Association Diabetes Alert Day®, March 23, 2021 Every fourth Tuesday in March, Diabetes Alert Day represents a one-day “wake-up call” that brings…
Read More
Join Echosens in helping raise awareness about the importance of early detection of liver disease.
The COVID-19 pandemic has emerged as a complicated and pernicious disease. Recently, the Centers for Disease Control and Prevention (CDC) warns that adults of any age with certain underlying medical conditions are…
Echosens and Healthy Trucking of America collaborate to improve liver health, safety and productivity of professional drivers During the COVID-19 pandemic, the nation’s professional drivers have been working harder than…
Primary care physicians and specialists face the challenges of addressing the epidemic of liver disease, including nonalcoholic fatty liver disease (NAFLD)–a silent and potentially reversible condition—and its subtype nonalcoholic steatohepatitis…
Scott Howell, DO, MPH & TM, CPE, Advisor to Echosens, was featured in OncologyTube interview: “Underlying Nonalcoholic Fatty Liver Disease is a Significant Factor for Breast Cancer Recurrence After Curative…
The prevalence of non-alcoholic fatty liver disease (NAFLD) has reached epidemic levels. The most common liver disease, with a worldwide prevalence of 25%, NAFLD and its subtype, nonalcoholic steatohepatitis (NASH),…
Join us in supporting World Diabetes Day, November 14, 2020, and National Diabetes Month this November! Echosens recognizes the importance of World Diabetes Day (WDD) and National Diabetes Month, and…
Join us in supporting Veterans Day, Nov. 11, 2020! Echosens is recognizing the importance of Veterans Day by celebrating the Department of Veterans Affairs’ (VA) victory in the battle against…
Echosens new Spleen Stiffness Measurement (SSM by VCTE™) delivers risk stratification of patients with cirrhosis and those with portal hypertension at risk for decompensation Superior to Liver Biopsy Liver…
